Editorial: Advances on targeted nanomedicines for atherosclerosis

Front Pharmacol. 2022 Oct 14:13:1053938. doi: 10.3389/fphar.2022.1053938. eCollection 2022.

Authors

Qinggong Han¹, Hongliang He¹, Yu Zhang¹

Affiliation

¹ State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Sciences and Medical Engineering, Southeast University, Nanjing, China.

Abstract

The importance of nanomedicines for atherosclerosis.

Keywords: atheroscelrosis; imaging; inflammation; macrophage; nanomedicine.

Copyright © 2022 Han, He and Zhang.

Publication types

Editorial